Nrg Oncology
Clinical trials sponsored by Nrg Oncology, explained in plain language.
-
New hope for limited metastatic breast cancer: targeted radiation or surgery may boost standard care
Disease control CompletedThis study looked at whether adding precise radiation (SBRT) or surgery to standard treatments (like chemo or hormone therapy) helps people with breast cancer that has spread to only one or two spots in the body. 129 participants were randomly assigned to receive standard care al…
Phase: PHASE2, PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 26, 2026 03:15 UTC
-
Can adding chemo to standard therapy prevent prostate cancer return?
Disease control CompletedThis study looked at 612 men with prostate cancer who had their prostate removed. It compared standard treatment (radiation plus hormone therapy) to the same treatment plus a chemotherapy drug called docetaxel. The goal was to see if adding chemo helps keep cancer from coming bac…
Phase: PHASE2, PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 26, 2026 03:13 UTC
-
New drug combo shows promise in keeping High-Risk prostate cancer at bay
Disease control CompletedThis study looked at adding a drug called niraparib to standard radiation and hormone therapy for men with high-risk prostate cancer. The goal was to see if the combination could lower the chance of the cancer growing or coming back. Twenty-two men took part, and the researchers …
Phase: PHASE1, PHASE2 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 26, 2026 03:13 UTC
-
Brain radiation study aims to protect memory in lung cancer patients
Disease control CompletedThis study tested whether avoiding the hippocampus during whole-brain radiation can help preserve memory and thinking in people with small cell lung cancer. About 418 patients with limited or extensive stage disease took part. The goal was to see if this technique reduces side ef…
Phase: PHASE2, PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 26, 2026 03:11 UTC
-
Could a diabetes drug boost lung cancer treatment?
Disease control CompletedThis study looked at whether adding metformin (a common diabetes medicine) to standard chemotherapy and radiation helps people with stage III non-small cell lung cancer live longer without their cancer growing. About 170 adults with this type of lung cancer took part. The goal wa…
Phase: PHASE2 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
Could less radiation be enough for certain throat cancers?
Disease control CompletedThis study looked at whether a lower dose of radiation therapy, with or without the chemotherapy drug cisplatin, is safe and effective for people with advanced oropharyngeal (throat) cancer that is linked to HPV (p16 positive) and occurs in non-smokers. About 316 participants wer…
Phase: PHASE2 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 11, 2026 20:52 UTC
-
Can fewer radiation sessions improve life after prostate surgery?
Symptom relief CompletedThis study tested whether a shorter course of higher-dose radiation (hypofractionated) is better than the usual longer course of radiation for men who had prostate cancer surgery. About 296 men took part. The main goal was to see how each approach affects urinary and bowel qualit…
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Symptom relief
Last updated May 26, 2026 03:09 UTC
-
Focused radiation beams take aim at multiple tumors in early trial
Symptom relief CompletedThis early-stage study tested a precise, high-dose radiation technique called stereotactic body radiotherapy (SBRT) in 42 people with breast, lung, or prostate cancer that had spread to several places in the body. The main goal was to find the safest dose and check for side effec…
Phase: PHASE1 • Sponsor: NRG Oncology • Aim: Symptom relief
Last updated May 26, 2026 03:04 UTC
-
Can a depression drug rekindle desire in cancer survivors?
Symptom relief CompletedThis study tested whether bupropion, a medication often used for depression, can improve low sexual desire in women who have had breast or gynecologic cancer. About 230 women took either bupropion or a placebo pill for 9 weeks. The goal was to see if the drug could safely boost d…
Phase: PHASE2 • Sponsor: NRG Oncology • Aim: Symptom relief
Last updated May 18, 2026 12:09 UTC
-
Heart health boost? study tests extra care planning for prostate cancer survivors
Knowledge-focused CompletedThis study looked at whether giving prostate cancer survivors on hormone therapy more detailed survivorship care plans helps them get better heart health follow-up. About 550 men who had radiation and hormone therapy took part. Researchers checked if patients saw their primary ca…
Phase: NA • Sponsor: NRG Oncology • Aim: Knowledge-focused
Last updated May 26, 2026 03:13 UTC